Aldesleukin Market to Grow Significantly with Increasing Advancements in Technology, Says QYR
Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene.
View full press release